tradingkey.logo
tradingkey.logo
検索

Rapid Micro Biosystems Inc

RPID
ウォッチリストに追加
2.070USD
-0.250-10.78%
終値 05/15, 16:00ET15分遅れの株価
94.74M時価総額
損失額直近12ヶ月PER

Rapid Micro Biosystems Inc

2.070
-0.250-10.78%

詳細情報 Rapid Micro Biosystems Inc 企業名

Rapid Micro Biosystems, Inc. is a life sciences technology company providing mission-critical automation solutions to facilitate the manufacturing and release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. Its flagship Growth Direct system automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in pharmaceutical manufacturing operations. It offers four specific applications for testing of microbial contamination: Environmental Monitoring, which tests the manufacturing environment, including circulating air, exposed surfaces, and personnel; Water, which tests any purified water used at any stage of the drug production process, including water for injection; In-Process Bioburden, which tests raw materials, drug substance and in-process product, and Sterility Release offering final testing of finished product to ensure sterility before the product is released for commercial sale.

Rapid Micro Biosystems Incの企業情報

企業コードRPID
会社名Rapid Micro Biosystems Inc
上場日Jul 15, 2021
最高経営責任者「CEO」Spignesi (Robert)
従業員数163
証券種類Ordinary Share
決算期末Jul 15
本社所在地25 Hartwell Avenue
都市LEXINGTON
証券取引所NASDAQ OMX - NASDAQ BASIC
United States of America
郵便番号02421
電話番号19783493200
ウェブサイトhttps://www.rapidmicrobio.com/
企業コードRPID
上場日Jul 15, 2021
最高経営責任者「CEO」Spignesi (Robert)

Rapid Micro Biosystems Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Richard S. Kollender
Mr. Richard S. Kollender
Independent Director
Independent Director
111.02K
+12.88%
Ms. Inese Lowenstein
Ms. Inese Lowenstein
Independent Director
Independent Director
38.60K
+37.05%
Mr. Natale S. (Nat) Ricciardi
Mr. Natale S. (Nat) Ricciardi
Independent Director
Independent Director
29.44K
+2.86%
Mr. Robert (Rob) Spignesi
Mr. Robert (Rob) Spignesi
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Sean M. Wirtjes, CPA
Mr. Sean M. Wirtjes, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Melinda Litherland
Ms. Melinda Litherland
Independent Director
Independent Director
--
--
Mr. John Wilson
Mr. John Wilson
Chief Operating Officer
Chief Operating Officer
--
--
Dr. Kirk D. Malloy, Ph.D.
Dr. Kirk D. Malloy, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. James Xu
Mr. James Xu
Senior Vice President - Legal, Company Secretary
Senior Vice President - Legal, Company Secretary
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Richard S. Kollender
Mr. Richard S. Kollender
Independent Director
Independent Director
111.02K
+12.88%
Ms. Inese Lowenstein
Ms. Inese Lowenstein
Independent Director
Independent Director
38.60K
+37.05%
Mr. Natale S. (Nat) Ricciardi
Mr. Natale S. (Nat) Ricciardi
Independent Director
Independent Director
29.44K
+2.86%
Mr. Robert (Rob) Spignesi
Mr. Robert (Rob) Spignesi
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Sean M. Wirtjes, CPA
Mr. Sean M. Wirtjes, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Melinda Litherland
Ms. Melinda Litherland
Independent Director
Independent Director
--
--

収益内訳

通貨: USD更新時刻: Mon, Apr 6
通貨: USD更新時刻: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
事業別USD
会社名
収益
比率
Product revenue
23.43M
69.75%
Service revenue
10.16M
30.25%
地域別USD
会社名
収益
比率
United States
13.43M
39.99%
Switzerland
6.02M
17.92%
All other countries
5.77M
17.18%
Germany
5.77M
17.17%
Japan
2.60M
7.73%
事業別
地域別
事業別USD
会社名
収益
比率
Product revenue
23.43M
69.75%
Service revenue
10.16M
30.25%

株主

更新時刻: Thu, May 14
更新時刻: Thu, May 14
株主統計
種類
株主統計
株主統計
比率
Bain Capital Life Sciences Investors, LLC
20.44%
Kennedy Lewis Investment Management LLC
11.97%
Longitude Capital Management Co., LLC
8.62%
Endeavour Medtech Growth II LP
5.47%
Ally Bridge Group (HK) Limited
4.48%
他の
49.02%
株主統計
株主統計
比率
Bain Capital Life Sciences Investors, LLC
20.44%
Kennedy Lewis Investment Management LLC
11.97%
Longitude Capital Management Co., LLC
8.62%
Endeavour Medtech Growth II LP
5.47%
Ally Bridge Group (HK) Limited
4.48%
他の
49.02%
種類
株主統計
比率
Investment Advisor
37.20%
Venture Capital
9.88%
Investment Advisor/Hedge Fund
6.28%
Corporation
5.47%
Individual Investor
4.45%
Hedge Fund
3.07%
Private Equity
1.40%
Research Firm
0.54%
Pension Fund
0.06%
他の
31.65%

機関投資家保有株

更新時刻: Wed, Apr 1
更新時刻: Wed, Apr 1
報告期間
機関投資家数
保有株式数
比率
変動額
2026Q1
67
25.08M
60.78%
+607.83K
2025Q4
59
23.36M
58.78%
-1.87M
2025Q3
56
23.72M
59.74%
-1.53M
2025Q2
68
28.04M
71.29%
+1.90M
2025Q1
76
27.59M
71.01%
+589.97K
2024Q4
81
24.48M
63.27%
-5.50M
2024Q3
105
26.74M
70.33%
-7.92M
2024Q2
116
27.58M
73.05%
-8.07M
2024Q1
141
28.00M
74.27%
-11.17M
2023Q4
153
28.87M
77.88%
-11.80M
詳細を見る

株主動向

会社名
保有株式数
比率
変動額
変動率
日付
Bain Capital Life Sciences Investors, LLC
8.43M
20.59%
--
--
Dec 31, 2025
Kennedy Lewis Investment Management LLC
4.94M
12.06%
--
--
Sep 30, 2024
Longitude Capital Management Co., LLC
4.08M
9.96%
-55.00K
-1.33%
Feb 03, 2026
Endeavour Medtech Growth II LP
2.26M
5.51%
--
--
Dec 31, 2025
Ally Bridge Group (HK) Limited
1.85M
4.51%
--
--
Dec 31, 2025
Spignesi (Robert G JR)
693.23K
1.69%
-17.92K
-2.52%
Mar 10, 2026
Advent International L.P.
577.78K
1.41%
--
--
Dec 31, 2025
Evernest Financial Advisors, LLC
125.00K
0.31%
-75.23K
-37.57%
Dec 31, 2025
詳細を見る

関連ETF

更新時刻: Sat, Dec 6
更新時刻: Sat, Dec 6
銘柄名
比率
iShares Micro-Cap ETF
0.02%
Dimensional US Core Equity 1 ETF
0%
Avantis US Small Cap Equity ETF
0%
iShares Micro-Cap ETF
比率0.02%
Dimensional US Core Equity 1 ETF
比率0%
Avantis US Small Cap Equity ETF
比率0%

配当金

過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし

株式分割

日付
配当落ち日
種類
比率
データなし
日付
配当落ち日
種類
比率
データなし
KeyAI